"novel lpxc inhibitors for the treatment of category a, B, and C bacterial infections"

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201500009C
Awardee
Awarding agency
Obligated
$4,733,101

Award facts

Opportunity
Contract value 100% obligated
$4,733,100.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 -$583,013
Other Administrative Action P00005 $0
Exercise an Option 4 $573,554
Funding Only Action 3 $308,943
Exercise an Option 2 $2,425,890
Supplemental Agreement for work within scope 1 $507,926
Original award $1,499,801

About this award

This is a $4,733,100.62 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Achaogen, Inc. for the development of "NOVEL LPXC INHIBITORS FOR THE TREATMENT OF CATEGORY A, B, AND C BACTERIAL INFECTIONS". The contract does not have a set-aside designation. The work is being performed in South San Francisco, California and the contract has an ultimate completion date of June 14, 2022.

Quick answers

Who was awarded contract HHSN272201500009C?

HHSN272201500009C was awarded to Achaogen, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 21, 2015.

How much is contract HHSN272201500009C worth?

The government has obligated $4,733,101 on HHSN272201500009C.

Was contract HHSN272201500009C competed?

The extent of competition for HHSN272201500009C was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award